# In Re: Da Vinci Surgical Robot Antitrust Litigation > District Court, N.D. California · December 10, 2022 URL: https://www.frixlaw.com/law-library/cases/10073800 ## Case - **Court:** District Court, N.D. California - **Decided:** December 10, 2022 - **Opinion:** 100trialcourt - **Cited by:** 0 later opinions in the Frix Law Library ## Citator (automated) - No negative treatment found by the automated citator. That is not the same as a confirmation that the case is good law; read the citing cases. - Full citator and citing cases: https://www.frixlaw.com/law-library/cases/10073800 ## Opinion text 1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 NORTHERN DISTRICT OF CALIFORNIA 10 San Francisco Division 11 LARKIN COMMUNITY HOSPITAL, et Case No. 21-cv-03825-VC (LB) al., 12 Plaintiffs, DISCOVERY ORDER 13 v. Re: ECF No. 106 14 INTUITIVE SURGICAL INC., 15 Defendant. 16 17 This case is a class-action antitrust lawsuit by classes of hospitals and other providers who 18 bought defendant Intuitive’s surgical-robot instruments and claim that Intuitive has violated the 19 antitrust laws by preventing them from using third parties to repair the instruments.1 Fact 20 discovery has closed, and the parties had no discovery disputes. This dispute is between Intuitive 21 and a third party, Alliance. 22 A third-party repair company called Restore, which sued Intuitive in the Northern District of 23 Florida, hired Alliance to help it get FDA 510(k) clearance to extend the use limits for a particular 24 Intuitive product by ten uses. In response to a third-party subpoena by Intuitive to Alliance in the 25 Restore litigation, Alliance produced 1700 pages dated between 2019 and April 2021 with a 26 27 1 1 limitation that they could be used only in the Restore litigation. In re Alliance Healthcare 2 Partners, LLC, No. MC-22-0033-PHX-DWL, 2022 WL 16527952, at *2, *7 (D. Ariz. Oct. 28, 3 2022) (addressing dispute and ultimately transferring this third-party subpoena to the Northern 4 District of California). Eventually Alliance agreed to produce them in this litigation, which was 5 efficient and practical: the complaint here says that the plaintiffs would have purchased 6 remanufactured EndoWrists from Restore.2 7 The dispute centers on the sufficiency of Alliance’s second production from April 2021 to July 8 2022. Essentially, the dispute involves a second search. In the letter brief, Intuitive asks for (1) 9 Alliance’s documents related to the 510(k) application (RFPs No. 5–9), (2) the pricing and costs of 10 remanufactured EndoWrists (RFP No. 2), and (3) Alliance’s relationship with Restore (RFP Nos. 4, 11 10).3 Alliance characterizes the dispute somewhat differently: it addresses 1 and 3 in its 12 characterization of the sufficiency of its production, it does not address 2, and it said at the hearing 13 that Intuitive’s dispute is limited to the three issues that it raised in its motion to compel in the 14 District of Arizona.4 To gain some clarity, the court did read the motion, opposition, and reply filed 15 in the District of Arizona (even though the letter-brief process here was meant as a replacement of, 16 and not a supplement to, discovery motions practice, whether here or elsewhere). 17 Federal Rules of Civil Procedure 45(d) and 26 guide the court’s enforcement of non-party 18 subpoenas. Under Rule 26(b)(1), a party may obtain discovery “regarding any nonprivileged 19 matter that is relevant to any party's claim or defense and proportional to the needs of the case, 20 considering the importance of the issues at stake in the action, the amount in controversy, the 21 parties’ relative access to relevant information, the parties’ resources, the importance of the 22 discovery in resolving the issues, and whether the burden or expense of the proposed discovery 23 outweighs its likely benefit.” The scope of discovery is the same under Rule 45. Fed. R. Civ. P. 45 24 advisory committee note to 1970 amendment (“the scope of discovery through a subpoena is the 25 26 2 Am. Compl. – ECF No. 74, ¶¶ 122, 156–57. Letter Br. – ECF No. 106 at 1. 27 3 Letter Br. – ECF No. 106 at 2. 1 same as that applicable to ... other discovery rules”); GreenCycle Paint, Inc. v. PaintCare, Inc., 2 No. 15-cv-04059-MEJ, 2018 WL 1399865, at *2 (N.D. Cal. Mar. 19, 2018). 3 “Non-parties that are unrelated to the litigants should not be burdened in discovery to the same 4 extent as litigants, and requests to them must be drawn narrowly to meet specific needs for 5 information. Updateme Inc. v. Axel Springer SE, No. 17-cv-05054-SI (LB), 2018 WL 5734670, at 6 *3 (N.D. Cal. Oct. 31, 2018) (collecting cases). Additionally, there are issues here involving a 7 competing lawsuit by competitors in the robot-repair industry, which is something to consider in 8 assessing Intuitive’s request and the parties’ positions. Cf. Waymo LLC v. Uber Techs., Inc., No. 9 17-cv-00939-WHA (JSC), 2017 WL 2929439, at *3 (N.D. Cal. July 7, 2017) (finding it significant 10 that discovery dispute “involve[d] a Rule 45 subpoena between direct competitors operating in the 11 same industry” in determining whether to quash request); In re Worlds of Wonder Sec. Litig., 147 12 F.R.D. 214, 216 (N.D. Cal. 1992) (denying motion to compel discovery from litigating party 13 where party’s confidential trade secrets would be disclosed to its competitors, who were serving as 14 expert witnesses). Generally, the party moving to quash bears the burden of persuasion, but the 15 party “issuing the subpoena must demonstrate that the information is relevant and material to the 16 allegations and claims at issue in the proceedings.” GreenCycle, 2018 WL 1399865, at *3. 17 Intuitive’s main concern is that — for the 510(k) application — it wants Alliance to use its 18 search terms because Alliance’s production was made by running the search term K210478 (the 19 FDA-assigned name for the 510(k) application) across the emails of two Alliance personnel. It 20 proposes a search with more terms.5 Alliance responded that that its search was sufficient to 21 produce its communications with the FDA. It says that it is a small company and suggests that 22 Intuitive is seeking the information to use in the Restore trial, which begins on February 6, 2023. 23 At the December 8, 2022 hearing on the dispute, it said that Intuitive had asked to reopen 24 discovery there, and the court there said no. Alliance also is concerned that the protective order 25 here is different than the protective order in the Florida case and does not want there to be issues 26 27 1 with the “Outside Counsel Only” designations.6 At the hearing, it affirmed that its search was 2 sufficient to identify the relevant communications with the FDA, it has produced them, and that 3 the proposed terms would yield an unhelpfully large and irrelevant amount of information. 4 The court accepts Alliance’s representation that its search is sufficient to identify all 5 communications with the FDA. Given that this is a second search after a sufficient production 6 through April 2021, whatever relevance there is for responsive information to a search with more 7 search terms does not outweigh the burden that would result from Alliance’s having to review a 8 large production for privilege and work product. (It is apparent from the court’s review of the 9 proposed search terms and the RFPs that the responsive hits would be large.) The core information 10 is the correspondence with the FDA. Limiting the post April 2021 production to that universe is 11 proportional to the needs of the litigation. Intuitive’s request for information about Alliance’s 12 relationship with Restore (RFP Nos. 4, 10) is cabined by this ruling: this second production is 13 sufficient. Given the Rule 45 standard and the context of the dispute, the court does not order more 14 on this record. 15 Another issue is use in the Florida litigation and the protective order. Discovery in the other 16 case is closed. The discovery here cannot be used there absent an order by that court. The 17 protective order here cannot be used as an end-run around the protective order in the Florida case. 18 Another issue may be the sufficiency of Alliance’s production of testing data. On this record 19 and argument, the production is sufficient. 20 The final issue is Intuitive’s request for documents and communications relating to the pricing 21 and costs of remanufactured EndoWrists (RFP No. 2). The parties did not address the dispute 22 squarely. On this record, considering the RFP, and given the production of information through 23 April 2021, the court cannot see how more discovery is proportional to the needs of the case. 24 Given that the parties do not frame the issues in the same way in the letter brief, this is the 25 court’s best effort at resolving the dispute. It probably would have been a more fruitful exercise if 26 the parties had talked again before filing the letter brief: they last talked by telephone on July 15 27 ] and emailed on July 22 and 27, and possibly Alliance produced information after that (although 2 || the court is not sure on this last point).’ If the court has overlooked something fairly raised in the 3 || underlying motion to compel and reiterated in the letter brief, then the parties can raise it in a new 4 || letter brief. But they need to talk first, preferably by video, and frame the dispute issue by issue. 5 This looks like a brief where the parties each pasted in their positions based on the underlying 6 || filings in Arizona, and they did not really respond directly to each other. Discovery disputes need 7 || to be addressed issue by issue. It was tough going here. 8 IT ISSO ORDERED. 9 Dated: December 10, 2022 LAUREL BEELER 10 United States Magistrate Judge 1] as 12 13 «14 16 17 Oo Z 18 19 20 21 22 23 24 25 26 27 28 1 Id. at 1. --- Source: Frix Law Library, https://www.frixlaw.com/law-library/cases/10073800. Public record. Not legal advice.